US Stocks
/
Oruka Therapeutics, Inc. Share Price
Oruka Therapeutics, Inc. Share Price

Oruka Therapeutics, Inc. Share Price

NASDAQ: ORKA | Mid Cap
$82.17
+$4.85 (6.27%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Oruka Therapeutics, Inc. Stock Performance

Open
$77.53
Prev. Close
$77.32
Circuit Range
N/A
Day Range
$77.37 - $82.08
Year Range
$22.28 - $115.52
Volume
54,474
Average Traded
$80.97

Oruka Therapeutics, Inc. Share Price Today

As of 11 October 2026, Oruka Therapeutics, Inc.'s share price is $82.17. The stock opened at $77.53, compared to its previous close of $77.32. During today's trading session, Oruka Therapeutics, Inc.'s share price traded between $77.37 and $82.08, with an average price of $79.72. Over the past 52 weeks, the stock has recorded a high of $115.52 and a low of $22.28. In terms of performance, Oruka Therapeutics, Inc.'s share price has risen by 19.73% over the last six months and is up 191.90% on a year-on-year basis.

Oruka Therapeutics, Inc. Share Price Chart

$77.37$82.08
L
Show Current Price
H

Oruka Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.75B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.74
Revenue (TTM)
$0.00
Return On Equity (TTM)
-10.34%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-45.05%

Oruka Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$24.04-$24.50-$31.82-$34.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.91%-29.88%-9.59%

Oruka Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$84.31
Net Profit MarginN/A
Income ChangeN/A

About Oruka Therapeutics, Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

Oruka Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$82.85
$81.90
-1.65%
Sep 2026
$91.37
$83.27
-13.63%
Aug 2026
$94.78
$96.41
-0.15%
Jul 2026
$94.76
$96.55
+1.44%
Jun 2026
$57.42
$95.17
+62.75%
May 2026
$68.50
$58.48
-14.79%
Apr 2026
$49.50
$68.63
+39.83%
Mar 2026
$33.70
$49.08
+42.63%
Feb 2026
$34.65
$34.41
+0.56%
Jan 2026
$30.35
$34.22
+12.77%
Dec 2025
$28.90
$30.34
+0.58%
Nov 2025
$27.39
$30.17
+7.18%

ORKA Share Price FAQs

What is Oruka Therapeutics, Inc. share price today?

chevron-up
Oruka Therapeutics, Inc. share price today is $82.17 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Oruka Therapeutics, Inc. stock?

chevron-up
The 52 week high of Oruka Therapeutics, Inc. stock is $115.52, while the 52 week low is $22.28 as of 10 Oct '26.

What is ORKA's market capitalisation today?

chevron-up
ORKA market capitalisation is $3.75B as of October 11, 2026, at 12:25 am IST.

What is ORKA's net income for the last quarter?

chevron-up
ORKA's net income for the last quarter is -34.87B USD.

What is the 5 year returns of ORKA?

chevron-up
The 5 year returns of ORKA is 149.91% as on 10 Oct '26.

What is the high & low stock price of ORKA today?

chevron-up
ORKA stock price hit a high of $82.08 and low of $77.37 as of 10 Oct '26.

Can I buy ORKA shares in India?

chevron-up
Yes. You can buy ORKA in India by opening an international trading account.